[1] Martínez-Laguna D, Tebé C, Nogués X,et al. Fracture risk in type 2 diabetic patients: a clinical prediction tool based on a large population-based cohort[J].PLoS One,2018,13(9):e0203533. [2] 雷颖庆. 糖尿病性视网膜病变患者视网膜病变程度与糖化血红蛋白水平及视网膜血管血氧饱和度的相关性研究[J].医学临床研究,2020,37(6):933-935. [3] Abu-Farha M, Al-Khairi I, Cherian P,et al. Increased ANGPTL3, 4 and ANGPTL8/betatrophin expression levels in obesity and T2D[J].Lipids Health Dis,2016,15(1):181. [4] 中华医学会糖尿病学分会.中国2型糖尿病防治指南(2013年版)[J].中华内分泌代谢杂志,2014,30(10):893-942. [5] 中华医学会眼科学会眼底病学组.我国糖尿病视网膜病变临床诊疗指南(2014年)[J].中华眼科杂志,2014,50(11):851-865. [6] Wu H, Wei Y, Shang Y,et al. iT2DMS: a standard-based diabetic disease data repository and its pilot experiment on diabetic retinopathy phenotyping and examination results integration[J].J Med Syst,2018,42(7):131. [7] 张铭. 内皮抑素抑制糖尿病视网膜新生血管生成中的研究进展[J].中华实验眼科杂志,2017,35(5):474-477. [8] Chadwick AC, Evitt NH, Lv W,et al. Reduced blood lipid levels with in vivo CRISPR-Cas9 base editing of ANGPTL3[J].Circulation,2018,137(9):975-977. [9] Yu CG, Yuan SS, Yang LY,et al. Angiopoietin-like 3 is a potential biomarker for retinopathy in type 2 diabetic patients[J].Am J Ophthalmol,2018,191:34-41. [10] Li WJ, Yin RX, Cao XL,et al. DOCK7-ANGPTL3 SNPs and their haplotypes with serum lipid levels and the risk of coronary artery disease and ischemic stroke[J].Lipids Health Dis,2018,17(1):30. [11] Xiao HB, Wang JY, Sun ZL.ANGPTL3 is part of the machinery causing dyslipidemia majorily via LPL inhibition in mastitis mice[J].Exp Mol Pathol,2017,103(3):242-248. [12] Gaudet D, Gipe DA, Pordy R,et al. ANGPTL3 inhibition in homozygous familial hypercholesterolemia[J].N Engl J Med,2017,377(3):296-297.
2021, Vol. 38 
